Table 1 Phase analysis results for patients whose unaltered activity ratio was > 90%
OSEM | TOSEM | |||||
|---|---|---|---|---|---|---|
AR (%) | BW (°) | StD (°) | ENT (%) | BW (°) | StD (°) | ENT (%) |
90 | 41.6 ± 15.2 | 14.1 ± 6.3 | 57.4 ± 5.3 | 49.9 ± 20.9 | 17.4 ± 7.6 | 59.6 ± 5.2 |
80 | 35.5 ± 10.9 | 11.5 ± 4.8 | 56.2 ± 4.9 | 49.3 ± 19.3 | 17.5 ± 7.3 | 59.8 ± 5.2 |
70 | 32.2 ± 9.4 | 9.6 ± 3.6 | 54.9 ± 4.9 | 49.6 ± 19.4 | 17.2 ± 7.0 | 59.6 ± 5.1 |
60 | 29.0 ± 8.0 | 8.0 ± 2.7 | 53.4 ± 4.8 | 51.2 ± 20.1 | 17.5 ± 7.2 | 59.6 ± 5.3 |
50 | 27.0 ± 7.1 | 7.2 ± 2.1 | 52.5 ± 4.7 | 48.5 ± 17.1 | 16.9 ± 6.9 | 59.9 ± 4.9 |